Cited 0 times in Scipus Cited Count

Correction of target-controlled infusion following the wrong selection of emulsion concentration of propofol

Other Title
목표농도주입법에서 프로포폴 농도를 잘못 설정 후 교정 방법
이, 원일
대학원 의학과
Master (2015)
Background: We investigated the correction methods following wrong-settings of emulsion

concentrations of propofol as a countermeasure against erroneous target-controlled infusions


Methods: TCIs were started with targeting 4.0 μg/ml of effect-site concentration (Ceff) of

propofol, and the emulsion concentrations were selected for 2.0% instead of 1.0% (FALSE1-

2, n = 24), or 1.0% instead of 2.0% (FALSE2-1, n = 24). These wrong TCIs were corrected at

3 min after infusion start. During FALSE1-2, the deficit was filled up while injecting after

equilibrium (n = 12), or while overriding (n = 12). During FALSE2-1, the overdose was

evacuated while targeting Ceff (n = 12) or targeting plasma concentration (Cp) (n = 12). The

gravimetrical measurements of TCI reproduced the Cp and Ceff using simulations. The

reproduced Ceff at 3 min (Ceff-3min) and the time to be normalized within ± 5% of target Ceff

(T±5%), were compared between the correction methods.

Results: During the wrong TCI, Ceff-3min was 1.98 ± 0.01 μg/ml in FALSE1-2, and 7.99 ± 0.05

μg/ml in FALSE2-1. In FALSE1-2, T±5% was significantly shorter when corrected while

overriding (3.9 ± 0.25 min), than corrected after equilibrium (6.9 ± 0.05 min) (P < 0.001). In

FALSE2-1, T±5% was significantly shorter during targeting Cp (3.6 ± 0.04 min) than targeting

Ceff (6.7 ± 0.15 min) (P < 0.001).

Conclusions: The correction methods, based on the pharmacokinetic and pharmacodynamic

characteristics, could effectively and rapidly normalize the wrong TCI following erroneously

selections of the emulsion concentration of propofol.

Appears in Collections:
Theses > School of Medicine / Graduate School of Medicine > Master
Ajou Authors
이, 원일
Full Text Link
Files in This Item:


해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.